Last reviewed · How we verify
topical vitamin B12
Topical vitamin B12 is thought to act as a coenzyme for methionine synthase, facilitating the conversion of homocysteine to methionine.
Topical vitamin B12 is thought to act as a coenzyme for methionine synthase, facilitating the conversion of homocysteine to methionine. Used for Treatment of vitamin B12 deficiency-related skin lesions.
At a glance
| Generic name | topical vitamin B12 |
|---|---|
| Sponsor | Ruhr University of Bochum |
| Target | Methionine synthase |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
This process is crucial for maintaining healthy skin and mucous membranes. Vitamin B12 deficiency can lead to skin lesions and other dermatological issues. Topical application of vitamin B12 may help alleviate these symptoms by replenishing the coenzyme and promoting normal cellular function.
Approved indications
- Treatment of vitamin B12 deficiency-related skin lesions
Common side effects
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain (PHASE4)
- Effect of Phonophoresis With Vitamin B12 on CTS (NA)
- Vitamin Supplementation After Bariatric Surgery (NA)
- Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis (NA)
- Topical Vitamin B12 in Chronic Plaque Psoriasis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- topical vitamin B12 CI brief — competitive landscape report
- topical vitamin B12 updates RSS · CI watch RSS
- Ruhr University of Bochum portfolio CI